BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22431319)

  • 1. Tumor type and single-cell/mesothelial-like cell pattern of breast carcinoma metastases in pleural and peritoneal effusions.
    Antic T; Gong Y; Sneige N
    Diagn Cytopathol; 2012 Apr; 40(4):311-5. PubMed ID: 22431319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleomorphic lobular carcinoma in pleural fluid: diagnostic pitfall for atypical mesothelial cells.
    Monaco SE; Dabbs DJ; Kanbour-Shakir A
    Diagn Cytopathol; 2008 Sep; 36(9):657-61. PubMed ID: 18677762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
    Goldstein NS
    Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors.
    Yuan Y; Leszczynska M; Konstantinovsky S; Tropé CG; Reich R; Davidson B
    Diagn Cytopathol; 2011 Aug; 39(8):562-6. PubMed ID: 20730893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of tumor cells from metastatic carcinoma of the breast in effusions.
    Danner DE; Gmelich JT
    Acta Cytol; 1975; 19(6):509-18. PubMed ID: 55031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic breast carcinoma in pleural fluid. Correlation of morphology with estrogen receptor activity and morphology of the primary carcinoma.
    Wiley EL; Von Roenn J
    Acta Cytol; 1990; 34(2):169-74. PubMed ID: 2321450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV; Nesland JM; Davidson B
    Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
    Ciampa A; Fanger G; Khan A; Rock KL; Xu B
    Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
    Spieler P; Gloor F
    Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
    Raju U; Ma CK; Shaw A
    Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions.
    Gioanni J; Caldani C; Zanghellini E; Mazeau C; Duplay H; Ferrua B; Schneider M
    Acta Cytol; 1991; 35(3):315-9. PubMed ID: 2042433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancies in Pleural, Peritoneal, and Pericardial Effusions.
    Dermawan JKT; Policarpio-Nicolas ML
    Arch Pathol Lab Med; 2020 Sep; 144(9):1086-1091. PubMed ID: 31913661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions.
    Bock AJ; Nymoen DA; Brenne K; Kærn J; Davidson B
    Hum Pathol; 2012 May; 43(5):669-74. PubMed ID: 21855113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytopathology of exocrine pancreatic carcinoma in effusions.
    Di Bonito L; Dudine S; Falconieri G
    Acta Cytol; 1991; 35(3):311-4. PubMed ID: 1710404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
    Davidson B; Baekelandt M; Shih IeM
    Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution pattern of concanavalin A on carcinoma cells, histiocytes and mesothelial cells from effusions.
    Lubínski J
    Acta Cytol; 1987; 31(2):99-103. PubMed ID: 3103357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.